Daiichi Sankyo is poised to report significantly lower full-year profit for fiscal year 2025, primarily due to a 95 billion Japanese yen ($610 million) hit linked to its precautionary antibody-drug ...
Abstract: ADC designs are progressing rapidly over time in terms of architectural developments and circuit innovations. In this talk, we will focus on high-precision designs and on low-power design ...
From Roche’s $1.4 billion licensing deal to AstraZeneca’s presidential symposium and an avalanche of clinical readouts, antibody-drug conjugates dominated Europe’s leading cancer conference over the ...
EBC-129 has been granted FDA fast track designation for the treatment of pancreatic ductal adenocarcinoma, paving the way for development of this antibody-drug conjugate. EBC-129, a novel ADC for the ...
As a creative individual, Jordan Tassiello has a track record of achievements in founding her own business and working with large companies on writing, editing, design, content creation and campaigns.
1 School of Automation and Information Engineering, Sichuan University of Science and Engineering, Yibin, China. 2 Sichuan Key Laboratory of Artificial Intelligence, Yibin, China. A 14-bit successive ...
[Igor] made a VU meter with LEDs using 8 LEDs and 8 comparators. This is a fast way to get one of 8 bits to indicate an input voltage, but that’s only the equivalent of a 3-bit analog to digital ...
Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Erika Rasure is globally-recognized as a leading consumer economics subject matter expert, ...
Despite some positive trials with new drugs (including immunotherapy) for recurrent cervical cancer, the prognosis for this disease remains poor and additional treatment options are needed. Tisotumab ...
An open-label, multicenter, phase I study of ATG-022 in patients with advanced/metastatic solid tumors (CLINCH). The design, preclinical study and phase I dose escalation plan of a HER2 targeted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results